Drug Shortage Report for PDP-ERYTHROMYCIN
Report ID | 62835 |
Drug Identification Number | 01912755 |
Brand name | PDP-ERYTHROMYCIN |
Common or Proper name | pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 5MG |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 50x1g |
ATC code | S01AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-10-02 |
Actual start date | 2018-10-02 |
Estimated end date | 2021-05-21 |
Actual end date | 2021-05-21 |
Shortage status | Resolved |
Updated date | 2021-05-22 |
Company comments | KINDLY NOTE THAT THE 3.5G FORMAT IS AVAILABLE |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v48 | 2021-05-22 | English | Compare |
v47 | 2021-05-21 | French | Compare |
v46 | 2021-05-21 | English | Compare |
v45 | 2021-05-17 | French | Compare |
v44 | 2021-05-17 | English | Compare |
v43 | 2021-04-22 | French | Compare |
v42 | 2021-04-22 | English | Compare |
v41 | 2021-02-12 | French | Compare |
v40 | 2021-02-12 | English | Compare |
v39 | 2021-02-12 | French | Compare |
v38 | 2021-02-12 | English | Compare |
v37 | 2021-01-18 | French | Compare |
v36 | 2021-01-18 | English | Compare |
v35 | 2020-11-18 | French | Compare |
v34 | 2020-11-18 | English | Compare |
v33 | 2020-11-18 | English | Compare |
v32 | 2020-05-19 | French | Compare |
v31 | 2020-05-19 | English | Compare |
v30 | 2020-03-05 | French | Compare |
v29 | 2020-03-05 | English | Compare |